|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.4600 - 0.4600|
|52 Week Range||0.0019 - 0.4600|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If you want to know who really controls Open Orphan plc ( LON:ORPH ), then you'll have to look at the makeup of its...
Federal government increasing state allotment of vaccines. Meanwhile, U.K. begins first human challenge trials.
Open Orphan (AIM:ORPH) announced the world’s first COVID-19 characterization study has received ethics approval in the UK.